| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Abdominal discomfort | Canada Vigilance: 1 | Canada Vigilance | |
| 2 | Accidental exposure to product | Canada Vigilance: 2 | Canada Vigilance | |
| 3 | Accidental exposure to product by child | Canada Vigilance: 2 | Canada Vigilance | |
| 4 | Accidental overdose | Canada Vigilance: 1 | Canada Vigilance | |
| 5 | Application site irritation | Canada Vigilance: 2 | Canada Vigilance | |
| 6 | Application site pain | Canada Vigilance: 1 | Canada Vigilance | |
| 7 | Crying | Canada Vigilance: 1 | Canada Vigilance | |
| 8 | Dyspepsia | 10604046 | CTD | |
| 9 | Erythema | Canada Vigilance: 1 | Canada Vigilance | |
| 10 | Eye pain | Canada Vigilance: 1 | Canada Vigilance | |
| 11 | Incorrect route of product administration | Canada Vigilance: 1 | Canada Vigilance | |
| 12 | Neurotoxicity Syndromes | 7482582 | CTD | |
| 13 | Pain of skin | Canada Vigilance: 1 | Canada Vigilance | |
| 14 | Pain | 10604046 | CTD | |
| 15 | Skin irritation | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.